文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

MR-linac自适应前列腺癌放疗工作流程中解剖变化对剂量学的影响

Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow.
PubMed 文献 · Radiat Oncol · 2020-07-10

本研究纳入35例前列腺癌患者,间隔30分钟采集两次MR图像,基于MR1制定7mm、5mm和3mm三种PTV margin的超大分割VMAT计划并重算至MR2,评估自适应重计划时间窗内解剖变化导致的剂量学影响。结果显示CTV平均质心偏移1.92mm,膀胱和直肠体积变化明显,7mm、5mm和3mm PTV margin下CTV剂量分别降低1.1%、2.0%和4.2%。结论提示自适应重计划时间窗内解剖变化可导致靶区欠剂量,治疗前需充分位置验证,引入margin缩小前需加快工作流程。

要点

  • 自适应重计划30分钟时间窗内CTV平均质心偏移1.92mm,膀胱和直肠体积变化显著。
  • 7mm、5mm、3mm PTV margin下CTV剂量分别降低1.1%、2.0%和4.2%。
  • 3mm PTV margin时CTV Dmin在两次计划间差异有统计学意义(p < 0.01)。

核心结论

  • 在MR-linac自适应重计划时间窗内发生的解剖变化可导致靶区欠剂量,膀胱和直肠体积变化引起前列腺大幅位移,提示治疗前需充分位置验证,且引入margin缩小前需加快工作流程。

研究设计与样本

  • 本研究为剂量学研究,纳入35例前列腺癌患者,间隔30分钟采集两次MR图像(MR1和MR2),基于MR1勾画CTV和OARs并利用sCT制定7mm、5mm和3mm三种PTV margin的超大分割VMAT计划,将MR1计划重算至MR2的sCT上以模拟自适应重计划30分钟后的实际剂量,采用形变配准量化解剖变化并将MR2剂量形变至MR1几何进行比较。

主要发现

  • CTV平均质心矢量偏移为1.92 mm [0.13 - 9.79 mm]。
  • 膀胱体积增加范围为12.4%至133.0%,直肠体积差异范围为-10.9%至38.8%。
  • 采用常规7 mm PTV margin时CTV剂量降低1.1%,5 mm和3 mm PTV margin对应值分别为2.0%和4.2%。
  • 所有评估的PTV margin下,PTV和OARs的剂量从D1至D2均降低。
  • 3 mm PTV margin时CTV Dmin在D1与D2之间差异有统计学意义(p < 0.01)。

临床怎么用

  • 前列腺癌MR-linac自适应放疗中,治疗前应进行充分的位置验证以应对膀胱和直肠体积变化引起的前列腺位移。
  • 在加快工作流程之前不宜引入PTV margin缩小,以避免自适应重计划时间窗内解剖变化导致的靶区欠剂量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose was to evaluate the dosimetric effects in prostate cancer treatment caused by anatomical changes occurring during the time frame of adaptive replanning in a magnetic resonance linear accelerator (MR-linac) workflow. METHODS: Two MR images (MR1 and MR2) were acquired with 30 min apart for each of the 35 patients enrolled in this study. The clinical target volume (CTV) and organs at risk (OARs) were delineated based on MR1. Using a synthetic CT (sCT), ultra-hypofractionated VMAT treatment plans were created for MR1, with three different planning target volume (PTV) margins of 7 mm, 5 mm and 3 mm. The three treatment plans of MR1, were recalculated onto MR2 using its corresponding sCT. The dose distribution of MR2 represented delivered dose to the patient after 30 min of adaptive replanning, omitting motion correction before beam on. MR2 was registered to MR1, using deformable registration. Using the inverse deformation, the structures of MR1 was deformed to fit MR2 and anatomical changes were quantified. For dose distribution comparison the dose distribution of MR2 was warped to the geometry MR1. RESULTS: The mean center of mass vector offset for the CTV was 1.92 mm [0.13 - 9.79 mm]. Bladder volume increase ranged from 12.4 to 133.0% and rectum volume difference varied between -10.9 and 38.8%. Using the conventional 7 mm planning target volume (PTV) margin the dose reduction to the CTV was 1.1%. Corresponding values for 5 mm and 3 mm PTV margin were 2.0% and 4.2% respectively. The dose to the PTV and OARs also decreased from D1 to D2, for all PTV margins evaluated. Statistically significant difference was found for CTV Dmin between D1 and D2 for the 3 mm PTV margin (p < 0.01). CONCLUSIONS: A target underdosage caused by anatomical changes occurring during the reported time frame for adaptive replanning MR-linac workflows was found. Volume changes in both bladder and rectum caused large prostate displacements. This indicates the importance of thorough position verification before treatment delivery and that the workflow needs to speed up before introducing margin reduction.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Mannerberg A, Persson E, Jonsson J, et al. Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow. Radiat Oncol. 2020. PMID: 32650811. doi:10.1186/s13014-020-01604-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。